Ozempic Lawsuit Update: Claims, Status & Who Can File

Last updated: October 23, 2026

More than 4,000 people have now filed federal lawsuits claiming Ozempic caused serious stomach injuries, and nearly 250 more are suing over sudden vision loss. Yet despite that volume, this Ozempic Lawsuit Update: Claims, Status & Who Can File report has one blunt fact up front: there is still no settlement, no payout, and no finished trial. Everything is pretrial.

If you or someone you love took Ozempic, Wegovy, Mounjaro, or a similar GLP-1 drug and then developed severe digestive problems or sudden vision changes, you’re probably trying to figure out where things stand and whether you qualify to file. This guide breaks down the claims, the current legal status, eligibility rules, and the mistakes that can sink a case before it starts.

Quick Answer

The Ozempic Lawsuit Update: Claims, Status & Who Can File picture as of October 2026: there are two active federal litigations, MDL 3094 for gastrointestinal injuries (about 4,025 cases) and MDL 3163 for vision loss (about 247 cases), both consolidated in the Eastern District of Pennsylvania [1][2]. No settlements, bellwether trials, or verdicts exist yet. Eligibility generally requires documented use of the drug, a qualifying diagnosis (like gastroparesis or NAION), and significant medical treatment.

Key Takeaways

• No Ozempic lawsuit settlements exist yet as of October 2026, all cases remain in pretrial litigation [3].
• Two separate federal MDLs are active: one for gastrointestinal injuries (MDL 3094) and one for vision loss/NAION (MDL 3163) [1][2][4].
• Roughly 4,025 gastrointestinal claims and about 247 vision-loss claims are currently pending.
• A key evidentiary hearing on expert testimony wrapped up with closing arguments on October 13, 2026, and rulings are still pending [2][3][5].
• Eligibility generally depends on documented drug use, a qualifying diagnosis, and medical treatment such as hospitalization or surgery [2][6].
• No bellwether trial dates have been scheduled in either MDL.
• You don’t need to still be taking the drug to potentially qualify, injury timing matters more than current use status.

What Is the Ozempic Lawsuit Actually About

The Ozempic lawsuit centers on claims that Novo Nordisk failed to adequately warn patients and doctors about serious gastrointestinal and vision risks tied to semaglutide. Plaintiffs argue the company knew or should have known about risks like gastroparesis, bowel obstruction, and NAION-related blindness before putting adequate warnings on the label [7][8].

Most lawsuits fall into one of two buckets:

• Gastrointestinal injury claims (MDL 3094): allegations of gastroparesis (stomach paralysis), ileus, bowel obstruction, pancreatitis, and gallstones after Ozempic, Wegovy, Mounjaro, or Trulicity use [1].
• Vision loss claims (MDL 3163): allegations that GLP-1 drugs triggered non-arteritic anterior ischemic optic neuropathy (NAION), a form of sudden, often permanent optic nerve damage [2][4].

A notable example: a wrongful-death suit filed March 5, 2026, alleges a patient died from complications tied to severe stomach paralysis that Novo Nordisk allegedly failed to warn about. Cases like this illustrate how serious the claimed harms can get, this isn’t just about nausea or temporary GI upset covered in standard side-effect lists.

If you’re newer to how these drugs work and what’s documented in clinical trials versus lawsuits, our overview of GLP-1 RA medication benefits is a useful companion read.

Who Is Eligible to File an Ozempic Lawsuit

You may be eligible if you used Ozempic or a related GLP-1 drug, were later diagnosed with a qualifying condition, and needed significant medical treatment as a result. Law firms and legal trackers generally point to three core eligibility criteria [2][6]:

1. Documented use of Ozempic, Wegovy, Rybelsus, Mounjaro, Trulicity, or Zepbound for diabetes or weight management.
2. A qualifying diagnosis, most commonly gastroparesis, bowel obstruction, severe GI disease, or NAION.
3. Significant medical treatment tied to that diagnosis, hospitalization, surgery, or long-term disability.

Decision rule: choose to pursue a claim if you have medical records showing both the prescription and the diagnosis timeline lining up, with a doctor connecting the two. Without that paper trail, a case is much weaker.

How Much Money Can You Get From an Ozempic Settlement

There is no verified settlement amount because no settlements have been reached in either MDL as of October 2026 [3]. Any number you see quoted online claiming specific payout ranges is speculation, not fact, treat those figures skeptically.

What we do know:

• No global settlement fund exists.
• No bellwether trial outcomes exist to set value benchmarks.
• Compensation, if it eventually materializes, would typically depend on severity of injury, medical costs, lost income, and permanence of harm, standard personal injury factors, not yet applied here.

Common mistake: believing marketing claims from unverified websites promising “guaranteed” payout amounts. No legitimate attorney can promise a dollar figure before liability is even established.

What Side Effects Are Covered in the Ozempic Lawsuit

The lawsuits cover severe, often hospitalization-level gastrointestinal injuries and vision loss, not routine side effects like mild nausea. Covered conditions generally include:

Condition	MDL	Description
Gastroparesis	3094	Stomach muscles stop working properly, causing severe nausea, vomiting, pain
Bowel obstruction / ileus	3094	Intestines become blocked or stop moving contents
Pancreatitis	3094	Inflammation of the pancreas, can require hospitalization
Gallstones	3094	Gallbladder complications sometimes requiring surgery
NAION (vision loss)	3163	Sudden, often permanent optic nerve damage

If your only experience was temporary nausea or appetite suppression that resolved without medical intervention, that typically does not qualify for litigation purposes [7][8].

When Can I File an Ozempic Lawsuit and What’s the Deadline

Filing deadlines depend on your state’s statute of limitations for product liability or personal injury claims, which typically runs from the date you discovered (or should have discovered) the injury’s link to the drug, not necessarily the date you first took it. Because deadlines vary by state and by injury type, this is one area where generic advice can hurt you.

Practical steps:

1. Gather prescription records and diagnosis dates now, even if you’re unsure about filing.
2. Consult an attorney promptly once you suspect a drug-related injury, waiting can forfeit your right to sue.
3. Don’t assume you’re too late; discovery-based rules in many states mean the clock may have started more recently than you think.

Edge case: if you were diagnosed years ago but only recently learned a doctor suspects a link to GLP-1 medication, the discovery rule may still allow you to file. This is exactly the kind of nuance a qualified lawyer should evaluate.

Do I Need a Lawyer to Join the Ozempic Lawsuit

Yes, you need an attorney to file an individual claim within the MDLs, these are not class actions you simply sign up for online. Each plaintiff files an individual lawsuit that gets consolidated into MDL 3094 or MDL 3163 for pretrial proceedings, but your case still needs its own legal representation [1][2].

What a lawyer typically does:

• Reviews your medical records to confirm you meet threshold criteria
• Files your case in the correct court
• Coordinates with the MDL’s pretrial schedule
• Represents you if your case is later selected for an individual trial or settlement track

Most personal injury attorneys handling these cases work on contingency, meaning you pay nothing upfront and fees come out of any eventual recovery, but confirm this arrangement in writing before signing anything.

What’s the Current Status of Ozempic Lawsuits in 2026

As of October 2026, both MDLs remain firmly in pretrial proceedings with no settlements, bellwether trials, or verdicts. The court has been working through “cross-cutting issues”, foundational legal and scientific questions that apply across all cases, before moving to individual case work [1][3].

Key recent developments:

• A Rule 702/Daubert evidentiary hearing on expert testimony was held September 14-18, 2026 [2][3][5].
• Closing arguments on expert-evidence motions took place October 13, 2026 [2][3][5].
• Rulings on those motions are still pending and will determine which scientific experts and evidence can be used going forward [3].
• No bellwether trial dates have been set in either MDL.

This matters because the Daubert rulings will essentially decide whether plaintiffs’ medical experts can testify about causation at all. If the judge excludes key expert testimony, it could significantly weaken many pending claims. If testimony is allowed, cases move closer to bellwether trials.

Ozempic Lawsuit for Thyroid Cancer Claims

Thyroid cancer is not currently a major focus of the consolidated gastrointestinal or vision-loss MDLs based on available litigation tracking data. The dominant claims in both active MDLs concern gastroparesis-related GI injuries and NAION vision loss [1][2][4]. If you believe you have a thyroid cancer claim specifically, [VERIFY: consult an attorney directly, as this may fall outside the current MDL structure] rather than relying on general litigation trackers.

Can You Sue Ozempic If You Stopped Taking It

Yes, stopping the medication does not disqualify you from filing a claim, as long as your injury developed during or shortly after use and is medically linked to the drug. Litigation claims focus on when the injury occurred and was diagnosed, not whether you’re a current user [2][6].

Example: someone who took Ozempic for 18 months, stopped due to severe GI symptoms, and was later diagnosed with gastroparesis can still potentially file, the diagnosis timing and medical documentation matter more than present-day usage status.

What Disqualifies You From the Ozempic Lawsuit

Lack of a qualifying diagnosis or insufficient medical documentation are the most common disqualifiers. Based on typical eligibility criteria used by firms handling these cases [2][6]:

• No formal diagnosis of gastroparesis, bowel obstruction, or NAION
• Symptoms that were mild and resolved without medical treatment
• Pre-existing GI or eye conditions with no new, distinguishable injury
• Inability to produce prescription or pharmacy records showing GLP-1 drug use
• Missing the applicable statute of limitations deadline for your state

Common mistake: assuming any digestive discomfort while on Ozempic automatically qualifies. The lawsuits target severe, medically documented injuries requiring treatment, not the common, labeled side effects like mild nausea that most users experience and that resolve on their own.

How Long Does an Ozempic Lawsuit Settlement Take

There is no fixed timeline because no settlement framework currently exists, but MDL litigation of this size typically takes years from filing to resolution. Complex pharmaceutical MDLs often take 3 to 5+ years to reach bellwether trials or global settlements, based on historical patterns in similar mass tort litigation, though this specific timeline for MDL 3094 and 3163 is not yet confirmed [VERIFY: current court scheduling orders].

What happens next, in order:

1. Daubert/expert evidence rulings (pending as of October 2026) [3]
2. Potential bellwether case selection
3. Bellwether trials (none currently scheduled)
4. Possible settlement negotiations based on bellwether outcomes
5. Individual case resolutions or a broader settlement program

If you file now, expect your case to move through these stages over a period of years, not months.

Ozempic Lawsuit vs Mounjaro Lawsuit: Which Is Bigger

The Ozempic-related gastrointestinal litigation is larger in case volume, but Mounjaro and other Eli Lilly drugs are consolidated within the same MDL 3094, not a separate court. MDL 3094 covers claims involving Novo Nordisk’s Ozempic, Wegovy, and Rybelsus, as well as Eli Lilly’s Mounjaro, Trulicity, and Zepbound [1][2].

Both companies are fighting these cases. Novo Nordisk is publicly contesting liability in the injury suits, while Eli Lilly maintains patient safety is its top priority, and notably, the two companies are separately suing each other over allegedly misleading GLP-1 advertising, unrelated to the injury claims [7][9].

Because both drug makers’ products sit in the same MDL, there isn’t really a “bigger lawsuit” in a separate court sense, it’s one consolidated proceeding covering multiple manufacturers and drugs.

For readers comparing these medications more broadly (not from a legal angle), our guide on which GLP-1 is best for weight loss covers the clinical differences.

Common Mistakes People Make Filing Ozempic Claims

The biggest mistake is waiting too long to gather records or consult a lawyer, risking both evidence loss and statute of limitations problems. Other frequent errors include:

• Relying on unverified payout estimates from random websites instead of a licensed attorney’s case evaluation
• Assuming mild side effects qualify when the litigation targets severe, treated injuries
• Not keeping pharmacy and medical records organized from the start
• Signing with multiple firms without understanding fee or referral agreements
• Ignoring state-specific deadlines by assuming a national rule applies everywhere

If you’re currently using a GLP-1 medication and experiencing concerning symptoms, that’s a conversation for your prescribing doctor first, not a reason to self-diagnose off a legal website.

Ozempic Lawsuit Stomach Paralysis and Gastroparesis Claims

Stomach paralysis, medically called gastroparesis, is the single largest category of claims within MDL 3094, affecting the majority of the roughly 4,025 pending gastrointestinal cases [1]. Gastroparesis occurs when stomach muscles fail to move food through the digestive system normally, causing severe nausea, vomiting, bloating, and in serious cases, malnutrition requiring hospitalization or feeding tubes.

Plaintiffs allege Novo Nordisk and Eli Lilly knew about this risk and failed to warn adequately on product labeling [7][8]. The wrongful-death case filed in March 2026 specifically cited stomach paralysis as a contributing factor in a patient’s death.

If you’re currently prescribed a GLP-1 medication and experiencing persistent vomiting, severe abdominal pain, or inability to keep food down, contact your doctor immediately, these can be signs of gastroparesis requiring urgent evaluation, separate from any legal considerations.

Frequently Asked Questions

Is there an Ozempic lawsuit settlement in 2026?
No. As of October 2026, no settlements exist in either MDL 3094 (gastrointestinal) or MDL 3163 (vision loss). Both remain in pretrial proceedings [3].

How many Ozempic lawsuits are currently pending?
Approximately 4,025 gastrointestinal injury lawsuits and about 247 vision-loss (NAION) lawsuits are pending as of early October 2026.

What court is handling the Ozempic lawsuits?
Both MDL 3094 and MDL 3163 are in the U.S. District Court for the Eastern District of Pennsylvania, with MDL 3094 overseen by Judge Karen S. Marston [1][2].

Can I file if I only used Ozempic for a short time?
Duration of use alone doesn’t disqualify a claim, but you need a documented, qualifying diagnosis connected to that use. Shorter use may make causation harder to establish, which is something an attorney should assess.

Does the lawsuit cover Wegovy and Mounjaro too?
Yes. MDL 3094 consolidates claims involving Ozempic, Wegovy, Rybelsus, Mounjaro, Trulicity, and Zepbound [1][2].

Are bellwether trials scheduled yet?
No. As of October 2026, no bellwether trial dates have been set in either MDL.

What’s a Daubert hearing and why does it matter here?
A Daubert (or Rule 702) hearing determines whether expert witness testimony is scientifically reliable enough to be admitted at trial. The hearing in MDL 3094 concluded with closing arguments on October 13, 2026, and the ruling will shape which evidence plaintiffs can use [2][3][5].

Should I stop taking my GLP-1 medication because of these lawsuits?
Don’t stop or change any medication without talking to your prescribing doctor first. Litigation status doesn’t replace personalized medical guidance about your specific health situation.

Conclusion

The honest state of the Ozempic Lawsuit Update: Claims, Status & Who Can File landscape in October 2026 is this: thousands of serious injury claims are pending, but nothing has been resolved, paid out, or decided at trial. Two federal MDLs, one for gastrointestinal injuries, one for vision loss, are working through foundational legal questions, with key expert-evidence rulings still pending. If you believe you have a qualifying injury, the most useful next step is gathering your medical and prescription records now and speaking with a personal injury attorney who specializes in GLP-1 litigation, rather than waiting on settlement news that hasn’t happened yet. For broader context on how these medications work and compare, see our guide to semaglutide brand names and differences.

This article is for informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting or changing any medication.

References

1. Glp 1 Receptor Agonist Mdl 3094. medicalrecords.com.
2. Glp 1 Lawsuit. larryformanlaw.com.
3. Ozempic Stomach Paralysis Lawsuit. schmidtandclark.com.
4. Ozempic Blindness Lawsuit. robertkinglawfirm.com.
5. Ozempic Glp1 Mdl. topdisputes.com.
6. Ozempic Lawsuit Alabama. callfob.com.
7. Compounded Glp 1 Injections Recalled Over Sterility Issues. drugwatch.com.
8. Lilly Novo Nordisk Sued Over Glp 1 Drug Safety. pharmaphorum.com.
9. Novo Sues Lilly Over Misleading Glp 1 Ad Campaigning. pharmaphorum.com.